Research ArticleRheumatoid Arthritis
Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Michael D. George, Joshua F. Baker and Alexis Ogdie
The Journal of Rheumatology June 2020, 47 (6) 826-834; DOI: https://doi.org/10.3899/jrheum.190299
Michael D. George
From the University of Pennsylvania, Division of Rheumatology, and Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics; Philadelphia Veterans Affairs Medical Center, Division of Rheumatology, Philadelphia, Pennsylvania,
USA.
Joshua F. Baker
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 47, Issue 6
1 Jun 2020
Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Michael D. George, Joshua F. Baker, Alexis Ogdie
The Journal of Rheumatology Jun 2020, 47 (6) 826-834; DOI: 10.3899/jrheum.190299